The CCR1 level on the OB was significantly higher in patients with MBD (74.48 ± 7.31%) than in the normal controls (48.35 ± 8.81%) (P <0.05) (Figure 3). This evidence concerns the gene CCR1 and Marchiafava-Bignami disease.